Most Recent
‘Disruptive and unsatisfactory’: Hytera slammed for late stage bid to adjourn copyright trial
Motorola has slammed Chinese radio manufacturer Hytera's "disruptive and unsatisfactory" request to adjourn a highly anticipated copyright trial over the alleged theft of source code which is due to begin in three weeks.
Pelvic mesh judge calls for ‘someone who understands how to plead a representative proceeding’
A judge has adjourned an interlocutory application because of deficient pleadings in a class action brought against three medical device manufacturers and a former doctor on behalf of thousands of women who claim to have suffered lifelong complications from pelvic mesh implants.
Bayer defeats Norbrook opposition to animal antiseptic patent
A delegate of IP Australia has tossed opposition by veterinary pharmaceutical company Norbrook Laboratories to a patent by rival animal health specialist Bayer New Zealand for a bovine antiseptic treatment.
‘The scheme has failed’: Court appoints provisional liquidators to Mayfair’s IPO Wealth
A court has appointed provisional liquidators to the IPO Wealth Group, rejecting claims by the firm's sole director that the move would severely damage his reputation and that of the wider Mayfair group.
‘Tabloid crusade’: Judges toss Daily Telegraph’s appeal in Geoffrey Rush defamation case
Daily Telegraph publisher Nationwide News has failed in its appeal of a judgment that found it defamed Geoffrey Rush in articles that accused the Oscar-winning actor of sexually inappropriate behaviour, with an appeals court describing the stories as a “sensationalised tabloid crusade”.
Spotless on the hook for redundancy pay after losing appeal
Cleaning services giant Spotless must pay redundancy entitlements to a group of workers it sacked, after failing to convince a court of appeal that it was exempt from making the payments.
Janssen to expand patent case against Juno over generic HIV drug
Drug manufacturer Janssen wants to expand its high stakes case against Juno Pharmaceuticals over its HIV drug Prezista, alleging Juno's plans to launch a generic version of the drug threaten another one of its patents.
Telstra must give Siemens identity details of potential copyright infringers
Telstra has been ordered to provide technology company Siemens Industry Software with all documents relating to the identity of account holders who may have infringed Siemens’ copyright.
Hytera can’t claim Motorola purposefully delayed notification of source code theft
A judge has rejected new evidence sought to be advanced by Hytera Communications in its IP battle with Motorola that Motorola deliberately delayed notifying Hytera of possible theft of its source code because it wanted to improve its market position.
Dentons can’t block use of info from its class action in latest toxic foam case by Shine
Shine Lawyers has been given the go ahead to use two reports produced in three settled PFAS class actions as evidence in its latest case over the Defence Department's firefighting foam, with a judge saying any implied undertaking not to re-use the material lost force when the information became public.